지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록· 키워드
오류제보하기
"Bioethics and Biosafety Act" was enacted in 2004.1.29. and will be in effect from 2005.1.1. except the inhibition of human cloning (article 11), the inhibition of implementation of different species (article 12) and its punishment clauses which were in effect immediately after enactment. This act is composed 9 chapters and 55 articles. In general rules (chapter 1), the aim, definitions, obligations and the principle of self determination are described. In ethical committee (chapter 2), the national and institutional review board have a ground to be founded. In embryonal research (chapter 3), human reproductive cloning is prohibited but the research on residual human embryo and therapeutic cloning using somatic cell nuclear transfer (SCNT) is permitted. Severe ethical debates were raised against this legislation. In genetic examination(chapter 4), the protection of genetic privacy, informed consent and withdrawal, access to and call for research records, request to abolish the genetic material is well equipped. But discrimination in favor of public sector is considered to violate the equal protection (article 24). In protection and use of genetic information (chapter 5), the discrimination due to the genetic difference is prohibited. The gene banking is permitted and the genetic information offer is allowed under the permission of institutional review board and should be noticed to the ministry of Health and Welfare. Personal information should be excluded from the genetic information offer. If medical documents are issued other than patient, genetic information should not be included. In gene therapy (chapter 6), for the treatment of life threatening disease or if the benefit of gene therapy overwhelms that of other therapy or officially determined disease for treatment or prevention, gene therapy is allowed. But the sperm, egg, embryo and fetus could not be objects of gene therapy (article 36).
This act will function as general principles of biomedical researches. But ethical debates are still on going and spread widely. The main debates are the allowance of human embryonal research and SCNT therapeutic cloning. Along with that, stem cell research including the use of fetal tissue, maternal protection will be the next themes to be discussed. Still we don't have any regulations. The genetic information as a common property of all mankind, we have to find a way to use it in a fair. Gene therapy could have effect beyond the generations, so the safety and quality of therapeutics is to be guaranteed. The proportions and authority of national and institutional ethical board should be adjusted for well￢functioning. We take a first step to regulate the bioethical and biosafety problems. More efforts will be needed to solve these problems.
This act will function as general principles of biomedical researches. But ethical debates are still on going and spread widely. The main debates are the allowance of human embryonal research and SCNT therapeutic cloning. Along with that, stem cell research including the use of fetal tissue, maternal protection will be the next themes to be discussed. Still we don't have any regulations. The genetic information as a common property of all mankind, we have to find a way to use it in a fair. Gene therapy could have effect beyond the generations, so the safety and quality of therapeutics is to be guaranteed. The proportions and authority of national and institutional ethical board should be adjusted for well￢functioning. We take a first step to regulate the bioethical and biosafety problems. More efforts will be needed to solve these problems.
목차
Ⅰ. 서론
Ⅱ. ‘생명윤리및안전에관한법률‘의 성격
Ⅲ. 국가생명윤리위원회 및 기관생명윤리위원회
Ⅳ. 배아연구
Ⅴ. 유전자 검사 및 정보 은행
Ⅵ. 유전자 치료
Ⅶ. 결론
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
생명공학에서의 분배정의와 사회인식도 조사
생명윤리
2005 .06
-
Bioethics and Biosafety Act
생명윤리
2004 .12
-
'생명윤리및안전에관한법률'에 대한 비판적 검토
생명윤리
2004 .06
-
유전자 치료에 대한 윤리적 고찰
생명윤리
2000 .05
-
유전정보에 대한 윤리적 쟁점의 변천
생명윤리
2014 .06
-
人間胚芽複製의 問題點과 解決方案 : 生命倫理法의 改善方案을 中心으로
생명윤리
2005 .06
-
생명윤리 및 안전 관련 입법정책
생명윤리
2003 .06
-
인간 유전체 기능 연구의 법적 문제
생명윤리
2002 .05
-
「생명윤리 및 안전에 관한 법률」상 심의면제의 의미 및 실무 개선의 제안
생명윤리
2019 .06
-
유전자편집 기술의 발전에 대응한 인간배아 유전자치료의 규제방향
생명윤리
2016 .06
-
인간 유전정보 보호와 시민참여
과학기술학연구
2003 .06
-
생명윤리 및 안전에 관한 법률과 유전자 윤리
생명윤리
2010 .06
-
한국의 생명복제 논쟁
생명윤리
2002 .05
-
인간 생식자, 배아 및 태아의 형사법적 보호
생명윤리
2011 .06
-
전부개정 된 「생명윤리 및 안전에 관한 법률」의 연구대상자 보호 측면에서의 의의와 한계
생명윤리
2014 .12
-
국가생명윤리심의위원회 구성 및 운영의 개선방안
생명윤리
2006 .06
-
인간개체복제에 관한 윤리적 논쟁들
생명윤리
2000 .05
-
인간 배아 및 생식계열의 유전적 변형(human Embryo and Germ-line genetic modification) 행위에 대한 용어 정의의 필요성과 그 용어의 조건
생명윤리
2020 .06
-
An analysis of the British and American policies on human cloning : What are the lessons for Korea?
생명윤리
2002 .05
-
유전상담사 자격인증 제도와 국내 석사학위 과정의 의료윤리 교육
생명윤리
2020 .06
이 논문의 저자 정보
이 논문과 함께 이용한 논문
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2010-570-002566950